1. Chen, Zhi, Wang, Kun, Hou, Canglong, Zhang, Caiguo, Shen, Hongxing. 2017. CRL4BDCAF11 E3 ligase targets p21 for degradation to control cell cycle progression in human osteosarcoma cells. In Scientific reports, 7, 1175. doi:10.1038/s41598-017-01344-9. https://pubmed.ncbi.nlm.nih.gov/28446751/
2. Park, Jee-Yun, Kim, Sunhyo, Sohn, Hee Young, Koh, Young Ho, Jo, Chulman. 2019. TFEB activates Nrf2 by repressing its E3 ubiquitin ligase DCAF11 and promoting phosphorylation of p62. In Scientific reports, 9, 14354. doi:10.1038/s41598-019-50877-8. https://pubmed.ncbi.nlm.nih.gov/31586112/
3. Djakbarova, Umidahan, Marzluff, William F, Köseoğlu, M Murat. 2016. DDB1 and CUL4 associated factor 11 (DCAF11) mediates degradation of Stem-loop binding protein at the end of S phase. In Cell cycle (Georgetown, Tex.), 15, 1986-96. doi:10.1080/15384101.2016.1191708. https://pubmed.ncbi.nlm.nih.gov/27254819/
4. Chen, Yicheng, He, Jinkui, Su, Changju, Li, Yining, Ding, Guoqing. 2019. LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA‑942. In Oncology reports, 42, 1924-1934. doi:10.3892/or.2019.7311. https://pubmed.ncbi.nlm.nih.gov/31545458/